ID   MTCQ1-GFP
AC   CVCL_A9X2
DR   Wikidata; Q102114559
RX   PubMed=31345390;
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Val214Leu (c.640G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Ile329_Asp390delins13; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9X0 ! MTCQ1
SX   Sex unspecified
AG   22-28W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
RX   PubMed=31345390; DOI=10.1016/j.oraloncology.2019.06.026;
RA   Chen Y.-F., Chang K.-W., Yang I.-T., Tu H.-F., Lin S.-C.;
RT   "Establishment of syngeneic murine model for oral cancer therapy.";
RL   Oral Oncol. 95:194-201(2019).
//